Page last updated: 2024-09-05

enzastaurin and melphalan

enzastaurin has been researched along with melphalan in 1 studies

Compound Research Comparison

Studies (enzastaurin)	Trials (enzastaurin)	Recent Studies (post-2010) (enzastaurin)	Studies (melphalan)	Trials (melphalan)	Recent Studies (post-2010) (melphalan)
188	52	99	8,134	1,351	1,972

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Armann, J; Baumann, P; Grün, G; Mandl-Weber, S; Oduncu, F; Schmidmaier, R	1

Other Studies

1 other study(ies) available for enzastaurin and melphalan

Article	Year
Inhibitors of protein kinase C sensitise multiple myeloma cells to common genotoxic drugs. European journal of haematology, 2008, Volume: 80, Issue:1 Topics: Antineoplastic Agents; Apoptosis; Bone Marrow; Carbazoles; Cell Proliferation; Cells, Cultured; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Indoles; Melphalan; Multiple Myeloma; Mutagens; Protein Kinase C; Protein Kinase Inhibitors	2008

Article

Year

Inhibitors of protein kinase C sensitise multiple myeloma cells to common genotoxic drugs.

European journal of haematology, 2008, Volume: 80, Issue:1

Topics: Antineoplastic Agents; Apoptosis; Bone Marrow; Carbazoles; Cell Proliferation; Cells, Cultured; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; Indoles; Melphalan; Multiple Myeloma; Mutagens; Protein Kinase C; Protein Kinase Inhibitors

2008